BRILINTA 60 mg/1
Ticagrelor · TABLET · AstraZeneca Pharmaceuticals LP
No Recall History
Plain English
BRILINTA is a tablet containing ticagrelor at 60 mg/1, taken oral. Manufactured by AstraZeneca Pharmaceuticals LP.
Key Facts
- Brand Name
- BRILINTA
- Generic Name
- Ticagrelor
- NDC Code (Product)
0186-0776- Manufacturer
- AstraZeneca Pharmaceuticals LP
- Strength
- 60 mg/1
- Dosage Form
- TABLET
- Route
- ORAL
- Marketing Status
- Application #
- NDA022433
- Drug Class
- P2Y12 Platelet Inhibitor [EPC]
- Marketing Start
- 09/04/2015
Recall History
No Recall HistoryFrequently Asked Questions
What is BRILINTA used for?
BRILINTA contains Ticagrelor. It is a tablet taken oral. Consult your doctor for specific uses.
Is BRILINTA a controlled substance?
BRILINTA is not classified as a controlled substance by the DEA.
What is the generic name for BRILINTA?
The generic name for BRILINTA is Ticagrelor. There are 12 other brand versions of Ticagrelor.
What is the NDC code for BRILINTA 60 mg/1?
The NDC (National Drug Code) for BRILINTA 60 mg/1 is 0186-0776, listed by AstraZeneca Pharmaceuticals LP.